Auxilium says Endo's offer "significantly undervalues" company
Sept 22 (Reuters) - Auxilium Pharmaceuticals Inc said its board had determined that Endo International Plc's offer "significantly undervalues" the company.
Endo made an unsolicited offer last week to buy Auxilium for about $2.2 billion.
Auxilium's board also reiterated on Monday that it backed the company's offer to buy Canadian eye drug maker QLT Inc . (Reporting by Ankur Banerjee in Bangalore; Editing by Kirti Pandey)
© Thomson Reuters 2017 All rights reserved.